DE3610873A1 - Phospholipid-vesikel und verfahren zu ihrer herstellung - Google Patents

Phospholipid-vesikel und verfahren zu ihrer herstellung

Info

Publication number
DE3610873A1
DE3610873A1 DE19863610873 DE3610873A DE3610873A1 DE 3610873 A1 DE3610873 A1 DE 3610873A1 DE 19863610873 DE19863610873 DE 19863610873 DE 3610873 A DE3610873 A DE 3610873A DE 3610873 A1 DE3610873 A1 DE 3610873A1
Authority
DE
Germany
Prior art keywords
hydroxide
liposomes
salt
quaternary ammonium
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19863610873
Other languages
German (de)
English (en)
Inventor
Adolfo Guillermo Ramat Sharet Jerusalem Gitman
Abraham Jerusalem Loyter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Genetic Sciences Partnership
Original Assignee
International Genetic Sciences Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Genetic Sciences Partnership filed Critical International Genetic Sciences Partnership
Publication of DE3610873A1 publication Critical patent/DE3610873A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19863610873 1985-04-04 1986-04-01 Phospholipid-vesikel und verfahren zu ihrer herstellung Withdrawn DE3610873A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71986285A 1985-04-04 1985-04-04

Publications (1)

Publication Number Publication Date
DE3610873A1 true DE3610873A1 (de) 1986-10-09

Family

ID=24891665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19863610873 Withdrawn DE3610873A1 (de) 1985-04-04 1986-04-01 Phospholipid-vesikel und verfahren zu ihrer herstellung

Country Status (16)

Country Link
JP (1) JPS61274739A (sv)
AU (1) AU585330B2 (sv)
BE (1) BE904536A (sv)
BR (1) BR8601554A (sv)
CA (1) CA1262863A (sv)
CH (1) CH668005A5 (sv)
DE (1) DE3610873A1 (sv)
ES (1) ES8802401A1 (sv)
FR (1) FR2579891B1 (sv)
GB (1) GB2188900B (sv)
IL (1) IL78348A (sv)
IT (1) IT1189877B (sv)
NL (1) NL8600794A (sv)
NZ (1) NZ215696A (sv)
SE (1) SE464448B (sv)
ZA (1) ZA862466B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
JPS63275522A (ja) * 1987-05-01 1988-11-14 Terumo Corp 人工赤血球及びその製造方法
JPH04283207A (ja) * 1991-03-13 1992-10-08 Kao Corp ベシクル及び重合体ベシクル
MY127839A (en) * 1996-10-25 2006-12-29 Monsanto Technology Llc Compositions and method for treating plants with exogenous chemicals
EP0936859B1 (en) 1996-10-25 2002-08-28 Monsanto Technology LLC Composition and method for treating plants with exogenous chemicals
WO2013039994A2 (en) * 2011-09-12 2013-03-21 Cure Pharmaceutical Corp. Apparatus, composition, and related methods for transdermal delivery of active ingredients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
DE3669503D1 (de) * 1985-01-07 1990-04-19 Syntex Inc Oberflaechenaktive n-(omega, omega-1-dialkoxy)- und n-(omega, omega-1-dialkenoxy)-alk-1-yl-n,n,n-trisubstituierte ammoniumverbindungen, deren herstellung und sie enthaltende pharmazeutische formulierungen.

Also Published As

Publication number Publication date
AU5562286A (en) 1986-10-09
NL8600794A (nl) 1986-11-03
BE904536A (fr) 1986-07-31
IL78348A (en) 1989-08-15
GB8608468D0 (en) 1986-05-14
GB2188900A (en) 1987-10-14
SE8601408L (sv) 1986-10-05
FR2579891A1 (sv) 1986-10-10
BR8601554A (pt) 1986-12-09
CA1262863A (en) 1989-11-14
ZA862466B (en) 1986-11-26
FR2579891B1 (sv) 1990-02-02
ES8802401A1 (es) 1988-05-16
NZ215696A (en) 1989-07-27
AU585330B2 (en) 1989-06-15
SE8601408D0 (sv) 1986-03-26
IL78348A0 (en) 1986-07-31
SE464448B (sv) 1991-04-29
IT1189877B (it) 1988-02-10
ES553703A0 (es) 1988-05-16
IT8683340A0 (it) 1986-04-03
CH668005A5 (de) 1988-11-30
GB2188900B (en) 1990-04-04
JPS61274739A (ja) 1986-12-04

Similar Documents

Publication Publication Date Title
EP1363601B1 (de) Amphotere liposomen und verwendung dieser
DE69535297T2 (de) Zubereitung multivesikulärer liposomen zur gesteuerten freisetzung von wirkstoffen
DE69533474T2 (de) Gerät und methode für die effiziente inkorporation von molekülen in zellen
DE69837339T2 (de) Veränderung der Wirkstoffladung in multivesikulären Liposomen
EP0152449B1 (en) Lipid vesicles prepared in a monophase
DE2907303A1 (de) Verfahren zur einkapselung biologisch aktiver substanzen
DE69633669T2 (de) Verfahren zur zelltransfektion mit liposomal-verkapselten nukleinsäuren
DE3751871T2 (de) Guanidinaminoglycosid enthaltende Liposome
EP1363933B1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
EP1289642B2 (de) Nanokapseln mit einer polyelektrolythülle
DE69433532T2 (de) Amphiphile imidazolinium-derivate
EP0043075A2 (de) Verfahren zur Erhöhung der Inkorporation und der Expression von genetischem Material in die Kerne von intakten Zellen mit Hilfe von Liposomen
EP0056781A2 (de) Verfahren zur Herstellung von liposomalen Arzneimitteln
WO2003070220A1 (de) Ph sensitiv kationische lipide, lipsomen und nanokapseln, die diese umfassen
EP1734928A2 (de) Serumstabile amphotere liposomen
EP0027662A1 (de) Eukaryotische Zellen und eukaryotische Protoplasten mit einem Gehalt an durch Lipidvesikel eingebrachter nackter DNA, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Gen-Produkten
DE3416978A1 (de) Durch liposom vermittelte transformation eukaryotischer zellen
DE3610873A1 (de) Phospholipid-vesikel und verfahren zu ihrer herstellung
EP0883624B1 (de) Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung
DE19736592C2 (de) Tetraetherlipidderivat, ein oder mehrere Tetraetherlipidderivate enthaltendes Liposom oder Lipidagglomerat und pharmazeutische Zusammensetzung
DE69108254T2 (de) Vesikel aus phospholipidderivaten mit einem succinimidylsubstituenten.
Papahadjopoulos Phospholipid membranes as experimental models for biological membranes
DE60219601T2 (de) Durch liposome vermittelte dna verabreichung
DE68905264T2 (de) Verfahren zur herstellung von proteoliposomen und verfahren zur herstellung von riesenproteoliposomen.
DE69824895T2 (de) Verfahren zur bestimmung des gens eines zielproteins mit hilfe eines medikamentes

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee